Herpes Genitalis

Approved for this indication (3)

• aciclovir
• famciclovir
• valaciclovir

Phase 4 trials (2)

• melatonin
• tenofovir

Phase 2 trials (16)

• pritelivir
• proflavine
• qs-21
• gen-003
• matrix-m2
• hsv2 dna vaccine
• ub-621
• vcl-hb01
• vcl-hm01
• herpv vaccine
• spl7013
• sodium chloride
• amenamevir
• meningococcal (group B) vaccine
• hdit101
• mrna-1608

Phase 1 trials (4)

• ag-707
• bnt163
• abi-5366
• abi-1179

Organization Involved with Phase 4 Indications (5)

• GlaxoSmithKline
• National Institutes of Health (NIH)
• National Institute of Allergy and Infectious Diseases (NIAID)
• University of Washington
• University of Sao Paulo

Organization Involved with Phase 3 Indications (6)

• Endo Pharmaceuticals
• Medical Research Council
• National Institute of Mental Health (NIMH)
• National Institute on Drug Abuse (NIDA)
• EMS S/A
• Bill and Melinda Gates Foundation

Organization Involved with Phase 2 Indications (16)

• Astellas
• AiCuris Anti-infective Cures GmbH
• Sanofi-Aventis
• Immune Design
• United BioPharma
• Vical
• Agenus Inc.
• Genocea Biosciences, Inc.
• Starpharma Pty Ltd
• French National Agency for Research on AIDS and Viral Hepatitis
• University of London
• Johns Hopkins University
• Medpace, Inc.
• University of Montpellier
• University of Paris
• Heidelberg ImmunoTherapeutics GmbH

Organization Involved with Phase 1 Indications (2)

• PowderMed
• The University of Texas, Dallas

Organization Involved with Other Experimental Indications (4)

• Roxane Laboratories
• University of North Carolina at Chapel Hill
• PRACS
• Centre for Infectious Disease Research in Zambia (CIDRZ)